| Literature DB >> 36134964 |
Arijit Nath1, Abubakar Saleh Ahmad1, Abraham Amankwaa1, Barbara Csehi2, Zsuzsanna Mednyánszky3, Emőke Szerdahelyi3, Attila Tóth4, Judit Tormási5, Duy Hoàng Truong6, László Abrankó5, András Koris1.
Abstract
The objective of the investigation was to understand the biochemical activities of hydrolysate of soybean milk protein (SMP). Hydrolysis was carried out by different concentrations of papain (0.008 g·L-1, 0.016 g·L-1, 0.032 g·L-1 and 0.064 g·L-1). The antioxidant capacity was measured by the ferric-reducing ability of plasma (FRAP) and 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assays. The anti-angiotensin activity of hydrolysate was measured by the recombinant angiotensin converting enzyme and substrate Abz-FRK(Dnp)-P. The contributions of the Kunitz trypsin inhibitor (KTI) and Bowman-Birk inhibitor (BBI) on antigenicity, and the in vitro digestion of papain-hydrolyzed SMP were studied. Rabbit polyclonal anti-KTI and anti-BBI antibodies together with peroxidase-labelled goat anti-Rb IgG secondary antibody were used to identify the antigenicity of KTI and BBI in unhydrolyzed and papain-hydrolyzed SMP. The antioxidant capacity and anti-angiotensin activity of SMP were increased after the papain hydrolysis of SMP. The KTI- and BBI-specific antigenicity were reduced in SMP by increasing the concentration of papain. However, there was interaction between papain-hydrolyzed SMP and trypsin in native gel, while interaction with chymotrypsin was absent. The interaction between trypsin and SMP was reduced due to the hydrolysis of papain in a concentration-dependent manner. According to the in vitro gastrointestinal digestion simulation protocol (Infogest), the digestibility of SMP was not statistically increased.Entities:
Keywords: anti-angiotensin activity; antigenic property; antioxidant capacity; digestibility; soybean milk protein
Year: 2022 PMID: 36134964 PMCID: PMC9495856 DOI: 10.3390/bioengineering9090418
Source DB: PubMed Journal: Bioengineering (Basel) ISSN: 2306-5354
Figure 1Image of SDS-PAGE of unhydrolyzed SMP papain-hydrolyzed SMP (A); DH of SMP using different concentrations of papain (B). The dissimilar alphabet in superscript represents the significant difference between results, evaluated by the Tukey’s post hoc method.
Figure 2Antioxidant capacity of unhydrolyzed and papain-hydrolyzed SMP (A). Mechanisms of antioxidant capacity for papain-hydrolyzed SMP (B). Antioxidant capacity of papain-hydrolyzed SMP with respect of DH (%) (C). Results are presented by mean value with standard deviation (± values). The dissimilar alphabet in superscript represents the significant difference between results, evaluated by the Tukey’s post hoc method.
Figure 3Uninhibited ACE activity (%) of unhydrolyzed and papain-hydrolyzed SMP (A). IC50 and maximum ACE inhibition (%) of unhydrolyzed and papain-hydrolyzed SMP (B). The Lineweaver–Burk plot of unhydrolyzed and papain-hydrolyzed SMP (C). The mechanism of ACE inhibition by peptide (D). Anti-angiotensin activity of papain-hydrolyzed SMP with respect of DH (%) (E). Results are presented by mean value with standard deviation (± values). The dissimilar alphabet in superscript represents the significant difference between results, evaluated by the Tukey’s post hoc method.
Figure 4Immunoblot of unhydrolyzed and papain-hydrolyzed SMP with Rb polyclonal antibodies: KTI (A) and BBI (B).
Figure 5Inhibitory activity of KTI in unhydrolyzed and papain-hydrolyzed SMP in native (non-denaturing condition) polyacrylamide gel (A), bioaccessible protein content and protein digestibility of unhydrolyzed and papain-hydrolyzed SMP in vitro digestion (B). Results are presented by mean value with standard deviation (± values). The dissimilar al-phabet in superscript represents the significant difference between results, evaluated by the Tukey’s post hoc method.